Clinical characteristics and comorbidities in psoriatic arthritis: Experience from a single rheumatology centre in Malaysia

被引:3
作者
Sulaiman, Wahinuddin [1 ,4 ]
Tan, Lay K. [2 ]
Mat, Hasnah [2 ]
Tohar, Najjah [2 ]
Fathi, Abdul Muhaimin [1 ]
Kosenin, Nia Maslia A. [1 ]
Naim, Muhammad N. [1 ]
Redzuan, Rafiqah F. [1 ]
Rani, Nur Iffah Ab [1 ]
Norhisham, Najiha A. [1 ]
Seung, Ong P. [3 ]
机构
[1] Univ Kuala Lumpur, Royal Coll Med, Fac Med, Dept Med, Perak, Malaysia
[2] Minist Hlth, Biostat & Data Repository Dept, Natl Inst Hlth, Shah Alam, Selangor, Malaysia
[3] Hosp Raja Permaisuri Bainun, Dept Med, Rheumatol unit, Perak, Malaysia
[4] Univ Kuala Lumpur, Fac Med, Dept Med, Royal Coll Med Perak, 3 Jalan Greentown, Ipoh 30450, Perak, Malaysia
关键词
Psoriatic arthritis; Psoriasis; Clinical features; Comorbidities; ANKYLOSING-SPONDYLITIS; EPIDEMIOLOGY; PREVALENCE; FEATURES; INVOLVEMENT; PATTERNS;
D O I
10.1016/j.ejr.2023.08.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim of the work: To evaluate the clinical features and associated comorbidities of psoriatic arthritis (PsA) patients from a single rheumatology centre in Malaysia.Patients and methods: 247 PsA patients in rheumatology clinic, Raja Permaisuri Bainun Hospital were included. Clinical and laboratory data were retrieved from the medical record.Results: The mean age was 56 +/- 13.5 years, 56.1% were female, and 38.9% were Indians. The onset of psoriasis and PsA was significantly earlier among Malays (P < 0.01) whilst Indians had longer disease duration (P < 0.05). The mean duration of progression from psoriasis to PsA was 8.7 years. Alcohol and nail dystrophy were common among Indians (P < 0.05). Plaque psoriasis was the commonest subtype (81%) in nails (pitting, 42.5%; onycholysis, 20.7%), scalp (35.6%) and limbs (32.8%). Pustular psoriasis and onycholysis were common in males (P = 0.05 and 0.002, respectively) whilst scalp psoriasis in females (P < 0.05). Peripheral arthritis was the highest (92.7%) compared to axial (8.1%); 14.6% had both. 38.9% were oligoarthritis and mostly asymmetrical (35.6%). 24% had enthesitis, 14.6% dactylitis, and 0.8% uveitis. 52.2% had hypertension, followed by dyslipidemia (44.1%), diabetes mellitus (34%), obesity (30%), ischemic heart disease (9.7%), cancer (2.4%), and tuberculosis (0.4%). No significant relationship between the pattern of arthritis and these comorbidities (P > 0.05).Conclusion: PsA was more prevalent in Indians. Malays have younger disease onset. Pustular psoriasis and onycholysis were common in males, while scalp psoriasis in females. Asymmetrical oligoarthritis and plaque psoriasis were the commonest pattern and psoriasis subtype respectively. Comorbidities were not associated with the pattern of arthritis in PsA patients.
引用
收藏
页码:309 / 313
页数:5
相关论文
共 50 条
  • [31] The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital
    Wang, Yiyi
    Xiao, Yue
    Li, Furong
    Gu, Yuanxia
    Yang, Min
    Zhang, Lingyan
    Tang, Jing
    Li, Wei
    RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 775 - 784
  • [32] The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital
    Yiyi Wang
    Yue Xiao
    Furong Li
    Yuanxia Gu
    Min Yang
    Lingyan Zhang
    Jing Tang
    Wei Li
    Rheumatology and Therapy, 2023, 10 : 775 - 784
  • [33] Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study
    Baviere, Wallis
    Deprez, Xavier
    Houvenagel, Eric
    Philippe, Peggy
    Deken, Valerie
    Flipo, Rene-Marc
    Paccou, Julien
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (03) : 369 - 376
  • [34] Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Ogdie, Alexis
    Chakravarty, Soumya D.
    Shiff, Natalie J.
    Lin, Iris
    McLean, Robert R.
    Malley, Wendi
    Spitzer, Rebecca L.
    Kavanaugh, Arthur
    Merola, Joseph F.
    DRUGS-REAL WORLD OUTCOMES, 2022, 9 (04) : 617 - 628
  • [35] BIOCHEMICAL AND CLINICAL CHARACTERISTICS OF PATIENTS WITH PRIMARY ALDOSTERONISM - SINGLE CENTRE EXPERIENCE
    Vujacic, Natasa
    Paunovic, Ivan
    Diklic, Aleksandar
    Zivaljevic, Vladan
    Slijepcevic, Nikola
    Kalezic, Nevena
    Stojkovic, Mirjana
    Stojanovic, Milos
    Beleslin, Biljana
    Zarkovic, Milos
    Ciric, Jasmina
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (02) : 240 - 248
  • [36] Early Origins of Psoriatic Arthritis: Clinical, Genetic and Molecular Biomarkers of Progression From Psoriasis to Psoriatic Arthritis
    Pennington, Stephen R.
    FitzGerald, Oliver
    FRONTIERS IN MEDICINE, 2021, 8
  • [37] Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting
    Armstrong, April W.
    Gelfand, Joel M.
    Boehncke, Wolf-Henning
    Armstrong, Ehrin J.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1434 - 1437
  • [38] A clinical and radiographic comparison of patients with psoriatic arthritis from different ethnic backgrounds
    Aslam, Tariq
    Mahmood, Farrouq
    Sabanathan, Anetha
    Waxman, Robin
    Helliwell, Philip S.
    RHEUMATOLOGY, 2021, 60 (01) : 340 - 345
  • [39] Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics
    Carubbi, F.
    Chimenti, M. S.
    Blasetti, G.
    Cipriani, P.
    Musto, A.
    Fargnoli, M. C.
    Perricone, R.
    Giacomelli, R.
    Peris, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (11) : 2160 - 2168
  • [40] CHARACTERIZATION AND RISK FACTORS FOR LUNG INVOLVEMENT IN PSORIATIC ARTHRITIS: DATA FROM A SINGLE RHEUMATOLOGIC CENTRE
    Monosi, B.
    Cristiano, I.
    Capparelli, E.
    Triggianese, P.
    Greco, E.
    Conigliaro, P.
    Kroegler, B.
    Fatica, M.
    Bergamini, A.
    Chimenti, M. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 742 - 742